Evidence has been presented in the preceding communication (1) indicating that cellular ribonucleic acid (RNA) plays an important role in the reproduction of deoxyribonucleic acid (DNA)-containing animal viruses. It was shown that 5,6-dichloro-1-/3-D-ribofuranosylbenzimidazole (DRB) 1 inhibits uptake of labeled adenosine into RNA of cells when present in concentrations inhibitory for vaccinia or adenovirus multiplication.
Evidence has been presented in the preceding communication (1) indicating that cellular ribonucleic acid (RNA) plays an important role in the reproduction of deoxyribonucleic acid (DNA)-containing animal viruses. It was shown that 5,6-dichloro-1-/3-D-ribofuranosylbenzimidazole (DRB) 1 inhibits uptake of labeled adenosine into RNA of cells when present in concentrations inhibitory for vaccinia or adenovirus multiplication.
The results of the present study with ribonuclease (RNase) and vaccinia and herpes simplex viruses have corroborated and expanded the results obtained with DRB.
Le Clerc (2) was the first to show that RNase inhibits the multiplication of an animal virus. Influenza A virus multiplication in the chorioallantoic membrane of embryonated chicken eggs was inhibited by crystalline bovine pancreatic RNase both in vitro and in vivo. RNase had no direct inactivating effect on influenza virus particles, and membrane tissue, the capacity of which to produce influenza virus had been markedly reduced by RNase, recovered this capacity after washing and incubation at 37°C. RNase inhibited influenza virus multiplication only when given within 2 hours after virus inoculation. It was also shown that RNase was capable of inhibiting adenine-C a* incorporation into membranes. The original observation (2) that RNase inhibits influenza virus multiplication in the chorioallantoic membrane has been confirmed (3).
The combined inhibitory effect of RNase and DRB on influenza B virus multiplication will be described. Inhibition by RNase of vaccinia virus multiplication in the chorioallantoic membrane in vitro and of pock formation in vivo will be reported. The relationship between time of administration of RNase cause influenza virus is almost completely liberated from the chorioallantoic membrane into the medium (7) whereas vaccinia virus is not released from the membrane to a significant extent (4) .
Hemagglutination Titration, L--Concentration of influenza virus was determined by hemagglutination fitrations. The technique used was described previously (6) . The yield was expressed in hemagglutinating units per milliliter. In chorioallantoic membrane cultures 3.8 cm. * of membrane was present per ml.
In]eaivi~y Ti~rations.--Concentration of vaccinia virus was determined by enumeration of pocks on the ectodermal surface of the dropped chorioallantoic membrane. The method used was described previously (4) . The yield was expressed in pock-forming units per milliliter. In chorioallantoic membrane cultures the amount of membrane per ml. was 3.8 cm3. The results of experiments recorded in Table I show that the three preparations of RNase possessed similar activity in inhibiting Lee virus multiplication. At a concentration of 12.5 gg. per ml. RNase caused 52 per cent reduction in yield of virus. At 50 and 200 ~g. per ml. the reduction was 66 and 92 per cent respectively. The relationship between concentration of RNase and virus yield is illustrated in Fig. 1 . Although inhibition of virus multiplication was obtained at low concentrations of RNase, inhibition was not complete at high concentrations. These findings are somewhat at variance with those reported earlier (2) . Le Clerc used several hundred micrograms of RNase in both in vitro and in vivo experiments, and obtained more than 99 per cent inhibition of PR8 virus multiplication in both. According to Dr. Le Clerc (8) the preparation of GBI RNase which was used in her experiments was more active than the Armour preparation employed in the present study.
Inhibition of PR8 Virus Multiplication by RNase.--The inhibitory activity
of RNase on Lee and PR8 virus multiplication was compared. Cultures of chorioallantoic membrane were prepared and used in a manner described above and the inoculum was 1.3 X 10 e EIDs0 of Lee or PR8 virus per ml.
RNase (Armour) at a concentration of 50 #g. per ml. caused 79 per cent inhibition of multiplication of Lee virus and 84 per cent inhibition of that of PR8 virus. Thus, the activity of RNase was similar with both viruses. 
Combined Effect of RNase and DRB on Lee Virus
Multiplication.--On the basis that both RNase and DRB are capable of disturbing RNA metabolism it would be expected that their combined inhibitory effect would exceed the inhibitory effect of either alone. This possibility was examined experimentally.
Cultures of chorioaUantoic membrane were prepared and used in a manner described above. The inoculum of Lee virus was 1.3 X 10 e EIDso per ml.
Results of three experiments are summarized in Table II . In experiments A and B the final concentration of DRB was 40/~ and that of RNase (Armour) was 12.5 #g. per ml. The mean of these two experiments indicates that DRB alone caused 83 per cent, RNase alone 64 per cent, and DRB plus RNase 94 per cent inhibition. Experiment C, in which lower concentrations of DRB and RNase were employed, gave a similar result. in 15 ml. of medium, suspended in 5 ml. of fresh medium or RNase solution, and reincubated for a total of 48 hours. The membranes were then homogenized in glass grinders with 12 ml. of fresh medium. The homogenates were centrifuged at 400 g for 5 minutes and the super° natants were collected and stored at --55°C. The yield of virus was determined by enumeration of pocks on the dropped CAM of embryonated chicken eggs and expressed in PFU per 3.8 cm. 2 of CAM.
Inhibition of Vaccinia Virus
Results obtained in two such experiments are summarized in Table III. As can be seen, RNase (GBI) at a concentration of 12.5 #g. per ml. caused 81 per cent reduction in yield of vaccinia virus. At 50 and 200 #g. per ml. the reduction was 84 and 94 per cent respectively. The relationship between concentration of RNase and virus yield is graphically illustrated in Fig. 2 . It is evident that inhibition of virus multiplication was obtained at low concentrations of RNase. However, complete inhibition was not obtained at the highest concentration used, which was 27 times greater than the 50 per cent inhibitory concentration. These findings are closely similar to the results obtained with influenza virus.
Inhibition of Vaccinia and Influenza Virus Multiplication in the Chorioallantoic Membrane Relative to Time of Addition of RNase.--To determine whether
RNase would inhibit vaccinia virus multiplication after infection had occurred, the enzyme was given at different times after inoculation of virus. A similar experiment was carried out with influenza virus.
In both experiments the membrane cultures were incubated at 35°C. for 48 hours. In the experiment with vaccinia virus the inoculum consisted of 7.7 X 10~ PFU of virus per ml. and the membranes were washed at 3 hours. RNase was added to a final concentration of 12.5 pg. per ml. at the time of virus inoculation or 10 or 24 hours later. Membranes were collected 48 hours after virus inoculation, homogenized, and the virus was measured by pock counts on the dropped chorioallantoic membrane of embryonated chicken eggs. In the experiment with influenza virus 1.3 X l0 s EID60 of virus was inoculated per ml. and RNase was added to a final concentration of 50 gg. per ml. at the time of virus inoculation or 3, 10, or 24 hours later. Culture medium was collected 48 hours after virus inoculation and the amount of virus present was determined by hemagglutination titrations.
In both experiments, control groups were included which received a volume of culture medium equal to that of RNase solution which was added to experimental groups. The yield of virus in the several control groups employed with each virus showed no systematic variation as a function of addition of 0.6 ml. of control medium at various intervals after virus inoculation and therefore the mean yieM in controls was used in computing per cent inhibition in treated cultures.
The results of these experiments are summarized in Table IV . As can be seen, RNase (GBI) caused marked inhibition of multiplication of both viruses when given 10 hours after inoculation.
The characteristic features of the relationship between time of introduction of RNase and extent of virus inhibition are readily seen in Fig. 3 in which virus yield is plotted against the interval, in hours, between introduction of virus and RNase. When virus and RNase were given simultaneously the yield of vaccinia virus was reduced by 78 per cent whereas that of influenza was reduced by 88 per cent. This small difference was probably due to the fact that concentration of RNase was 4 times higher with influenza than with vaccinia virus. As was pointed out earlier, the inhibitory effect of RNase on both vaccinia and influenza virus multiplication increased only slightly when concentrations higher than 10 #g. per ml. were used.
With vaccinia virus considerable inhibition was obtained even when administration of enzyme was delayed for 24 hours. In contrast, with influenza virus, little inhibition was obtained when RNase was given 24 hours after virus inoculation.
These results indicate that RNase was inhibitory when given a considerable time after adsorption of the inoculated virus had taken place. However, the results do not provide information as to when RNase acts during a single multiplication cycle because the experiments were of the multiple cycle type. The difference in the inhibitory effect of RNase on vaccinia and influenza virus multiplication, which was observed when the enzyme was given at 24 hours after virus inoculation, was probably due to two factors: (a) The amount of virus taken up by cells under the conditions of these experiments was much greater with influenza (7) than vaccinia (4) virus; consequently the number of cycles of multiplication was probably greater with influenza than with vaccinia virus. (b) The latent period of vaccinia virus multiplication is 2 to 3 times longer than that of influenza virus multiplication. Both of these factors would tend to prolong the interval during which vaccinia multiplication may be expected to be susceptible to inhibition by an agent such as RNase. Embryonated eggs were prepared as was described above and six eggs were used per variable. The stock suspension of vaccinia virus was diluted 1.4 X 10 e times and aliquots of the diluted virus suspension were mixed with equal volumes of RNase solutions of varying concentration. The mixtures were inoculated on the ectodermal surface of the dropped chorioallantoic membrane. Each egg received 0.2 ml. Controls received virus, but no ribonuclease. Eggs were incubated at 35°C. for 48 or 72 hours. The infected portions of chorioallantoic membrane were then collected and the pocks formed were examined and counted.
Inhibition of Formation of Vaccinia Virus Pocks by
The results of twelve such experiments with GBI RNase are summarized in Table V The relationship between the amount of RNase and inhibition of pock formation is graphically illustrated in Fig. 4 . In the dose range of RNase from 1.56 to 12.5 #g. per egg the inhibitory effect was markedly dependent on the amount of enzyme. Further increase in the amount of RNase had little effect on the degree of inhibition. Even with several hundred micrograms per egg inhibition was incomplete.
The dose-effect relationship observed in these in rivo experiments is closely similar to the relationship between RNase concentration and inhibition of vaccinia or influenza virus multiplication in the chorioallantoic membrane in vitro.
In a series of three experiments the activity of several preparations of RNase was compared. The degree of inhibition of pock formation induced by 12.5 ~tg. of RNase per egg was as follows: two preparations of GBI RNase, 64 and 56 per cent, respectively; Armour, 72 per cent; Sigma, 66 per cent; and Worthington, 69 per cent. Thus the five preparations of RNase possessed similar activity. The mean reduction in pock count was 65 per cent. in herpes simplex virus is of the DNA type (9, 10). Furthermore, this virus also forms pocks on the dropped chorioallantoic membrane of the embryonated egg. Experiments were therefore undertaken to see whether RNase would inhibit pock formation by herpes virus.
Inhibition of Formation of Herpes Virus Pocks by RNase on the Chorioallantoic Membrane in
Embryonated eggs were prepared as was described above, and 12 eggs were used per variable. Aliquots of diluted virus suspension were mixed with RNase solutions of varying concentration and the mixtures were inoculated on the ectodermal surface of the dropped chorioailantoic membrane. Each egg received 0.2 ml. Controls received virus, but not RNase. Eggs were incubated at 35°C. for 48 hours either in the usual horizontal position with the false air sac facing upward or in the vertical position with the blunt end of the egg facing upward. The inoculum is distributed over a larger area when the latter procedure is used (11) . The advantages of vertical incubation are considerable with herpes virus but they are less significant with vaccinia. After incubation the infected portions of chorioallantoic membrane were collected and the pocks formed were examined and counted.
As can be seen in Table VI RNase (GBI) caused marked inhibition of formation of herpes virus pocks. The effect was more marked when the embryonated eggs were incubated in the horizontal position. Under these conditions the inoculum remained more localized and therefore the dose of RNase per unit area of membrane was higher. It should be emphasized that at comparable virus dilutions confluent lesions were much more common when the eggs were incubated in the horizontal position which made precise quantitation difficult. The results of these experiments are graphically represented in Fig. 5 . As can be seen 12.5/zg. of RNase caused a considerable reduction in the number of pocks. However, 200 ~g. failed to cause complete inhibition. These characteristics of the dose-effect relationship were also observed with vaccima and influenza viruses.
In a series of three experiments the inhibitory activity of several preparations of RNase on pock formation by herpes virus was compared. The eggs were incubated in the vertical position. The degree of inhibition induced by 12.5 /~g. of RNase per egg was as follows: two preparations of GBI RNase, 46 and 43 per cent, respectively; Armour, 24 per cent; Sigma, 41 per cent; and Worthington, 23 per cent. In the fourth experiment 50/zg. of RNase was employed per egg and the following results were obtained: two preparations of GBI, 55 and 62 per cent inhibition, respectively; Armour, 61 per cent; Sigma, 71 per cent; and Worthington, 55 per cent. Thus, the inhibitory activity of the five preparations was similar. The mean reduction in pock count with 12.5 t~g. o~ RNase was 36 per cent and with 50 tzg. it was 61 per cent.
Lack of Inactivating Effect of RNase on Infectivity of Vaccinia and Herpes
Simplex Viruses.--It has been shown that RNase does not cause inactivation of the infectivity of influenza virus particles (2) . Experiments were carried out to determine whether RNase had an inactivating effect on vaccinia or herpes virus particles. Vaccinia and herpes virus seeds, diluted 10 -2 in buffered glucosol were incubated at 35°C. in the absence or presence of t25 t~g. per ml. of RNase. With vaccinia virus the period of incubation was 24 hours. Herpes virus was incubated for 3 hours because of its thermal instability. After incubation the content of infective virus was determined by enumeration of pocks on the dropped chorioaUantoic membrane. In the preparation of inocula of suitable concentration for pock counts, concentration of RNase was reduced by dilution below the levels at which it has a detectable effect on pock formation by vaecinia or herpes virus. Table VII show that RNase at high concentration did not inactivate the infectivity of vaccinia or herpes virus particles. In these experiments GBI RNase was employed. The effect of Worthington RNase on infectivity of vaccinia virus was also investigated and no inactivation of vaccinia virus infectivity was found.
Results of experiments summarized in

Effect of RNase on the Size of Vaccini~ and Herpes Virus Pocks.--In the
course of studies on the effects of RNase on the number of vaccinia and herpes virus pocks, the impression was gained that the pocks which formed in the presence of RNase were on the average somewhat smaller than those in un-treated controls. This observation was confirmed in experiments in which the membranes bearing pocks were photographed and the pocks measured.
Embryonated eggs were prepared as was described above, and 6 eggs were used per variable. Aliquots of diluted virus suspension with or without RNase were inoculated on the ectodermal surface of the dropped chorioallantoic membrane. Each egg received 0.2 ml. Eggs were incubated at 35°C. for 48 hours in the horizontal or vertical position. The infected portions of the chorioallantoic membrane were then collected and photographed. Photographs of vaccinia virus infected membranes were enlarged 1.73 times whereas those of herpes virus infected membranes were enlarged 3.30 times. The longest and shortest diameters of each pock were measured, and a mean diameter computed. The mean diameter of all pocks on each egg was then computed, and finally a grand mean for 6 eggs taken.
As can be seen in Table VIII vaccinia or herpes virus pocks formed in the presence of RNase were on the average 10 per cent smaller than those formed in untreated controls. The effect of RNase on the number of pocks was much greater than the effect on pock size. This suggests that RNase had little direct effect on the development of accumulations of leucocytes which form the major pathological feature of pocks.
DISCUSSION
The concept that host RNA may play an important role in virus multiplication was advanced several years ago (12) That RNA synthesis is stimulated in cells infected with DNA-containing vaccinia virus has been well established. Caspersson and Thorsson (13) found that within a short time after infection of chorioallantoic membrane cells of embryonated chicken eggs with vaccinia virus the nucleoli became enlarged and the content of cytoplasmic nucleotides increased markedly. More recently it was shown (14) that cytoplasmic RNA was considerably increased in HeLa cells infected with vaccinia virus. These findings contribute greatly to knowledge of metabolic alterations which occur in virus-infected cells; however, they do not provide evidence as to whether RNA is necessary for synthesis of vaccinia virus particles.
The demonstration that DRB is inhibitory for vaccinia virus multiplication at the same low concentrations which are inhibitory for multiplication of influenza virus (15) , combined with the evidence that DRB inhibits incorporation of precursors into RNA strongly suggested that RNA is, indeed, necessary for vaccinia virus synthesis (1) . The results of the present study with RNase provide additional evidence in support of this conclusion. Furthermore, evidence was obtained that herpes virus multiplication is also dependent on RNA. There is cytochemical evidence that herpes virus contains DNA (9, 10) . In the preceding communication it was shown that multiplication of the DNAcontaining adenovims in monkey kidney cells was as susceptible to inhibition by DRB as that of influenza virus. Thus, it appears that RNA plays a definite role in the multiplication of three DNA-containing animal viruses: vaccinia, adenovirus, and herpes virus.
As was emphasized above, close similarity was observed in the relationships between concentration of RNase and its inhibitory effects on influenza and vaccinia virus multiplication and on pock formation by vaccinia and herpes viruses. This suggests a common mechanism of action in all cases, and there-fore it appears likely that even with influenza virus, which contains RNA, RNase may be inhibitory because of its effect on host cell RNA. Although Le Clerc (2) showed that RNase markedly reduced the uptake of adenine-C ~4 into chorioallantoic membranes, her preferred hypothesis of the mechanism of action of RNase was that the enzyme might act on free virus nucleic acid after separation of infecting virus particles into ribonucleic acid and protein inside host cells. That such may be the case is possible. Thus, RNase may inhibit influenza virus multiplication through either or both of the two mechanisms suggested.
It is of great interest that RNase had no effect on incorporation of C ~-phenylalanine (2) , and that the inhibitory effect of DRB on uptake of C 14-L-alanine into proteins of the chorioallantoic membrane was slight (1). These findings suggest that RNase and DRB inhibit the multiplication of DNAcontaining viruses not because of a secondary effect on the synthesis of host cell enzymes which are of importance in keeping the host cell and the multiplying virus supplied with energy and precursor materials. It appears, rather, that the mechanism of the inhibitory effect on virus yield may be more direct and may involve some function of cell RNA in the synthesis of virus proteins. The possibility suggests itself that inhibition of virus multiplication may be due to a disturbance in the function of soluble low molecular weight RNA as carrier of activated amino acids. Hoagland et al. (16) found that transfer of activated amino acids to soluble RNA was sensitive to RNase. The enzyme acts on the phosphate bridge between terminal adenosine and adjacent cytidine of soluble RNA and as a result terminal adenosine is split off. Such an alteration in soluble RNA would interfere with the transport of activated amino acids which are linked to terminal adenosine of soluble RNA and are carried in this form through further steps in protein synthesis (17) . Inhibition of protein synthesis in living onion roots treated with RNase appears to be due to partial breakdown of soluble RNA by the enzyme (18) .
If it be true that RNase inhibits virus multiplication through interference with the transport mechanism of activated amino acids to sites of synthesis of virus proteins, it follows that host cell protein synthesis is less sensitive to inhibition by this mechanism because RNase had no effect on uptake of C ~-phenylalanine into proteins of the chorioallantoic membrane (2). Indeed, it appears that host protein synthesis in the chorioallantoic membrane is unusually insensitive to the action of both RNase and DRB, because both of these agents do inhibit amino acid uptake into proteins in other systems (1, (19) (20) (21) (22) (23) .
Certain other possibilities should also be considered to explain the mechanism of inhibitory action of RNase on multiplication of DNA-containing viruses; inhibition may be due to disturbance of the possible template function of high molecular host cell RNA in synthesis of virus proteins. However, too little is known about the template function of RNA in protein synthesis to permit a detailed consideration of this possibility. Finally, the possibility should be considered that in cells infected with a DNA-virus new RNA is synthesized which plays a specific role in the reproduction of the particular virus, and that the effects of RNase and DRB are due to interference with this new RNA.
SUMMARY
Ribonudease is a highly active inhibitor of vaccinia virus multiplication in vitro in the chorioallantoic membrane removed from embryonated chicken eggs. It is also a highly active inhibitor of pock formation by vaccinia and herpes simplex viruses on the chorioallantoic membrane in vivo. Marked inhibitory effects were obtained with 12.5 #g. of RNase. However, complete inhibition was not obtained with several hundred micrograms of the enzyme.
RNase caused no inactivation of the infectivity of vaccinia virus particles but it had a marked inhibitory effect on multiplication of this virus when administered many hours after infection of host cells had occurred. RNase also failed to inactivate the infectivity of herpes simplex virus particles.
The results obtained indicate that ribonucleic acid is necessary for the multiplication of two DNA-containing viruses; i.e., vaccinia and herpes simplex. 
